Moderna announced that the U.S. Food and Drug Administration (FDA) has refused to consider its application for a new flu vaccine using mRNA technology.
FDA refuses to review Moderna’s application for mRNA flu vaccine
Katherine Mosack
Feb 11, 2026 | 4:42 PM
We use cookies for various purposes including analytics and marketing. By continuing to use this service, you agree to use cookies by us and our third-party service providers as described in the Privacy Policy.